- Home
- MQT vs ZYXI Comparison
MQT vs ZYXI Comparison
Compare MQT & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MQT
- ZYXI
- Stock Information
- Founded
- MQT 1992
- ZYXI 1996
- Country
- MQT United States
- ZYXI United States
- Employees
- MQT N/A
- ZYXI N/A
- Industry
- MQT Investment Bankers/Brokers/Service
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MQT Finance
- ZYXI Health Care
- Exchange
- MQT Nasdaq
- ZYXI Nasdaq
- Market Cap
- MQT 228.6M
- ZYXI 248.4M
- IPO Year
- MQT N/A
- ZYXI N/A
- Fundamental
- Price
- MQT $10.32
- ZYXI $8.11
- Analyst Decision
- MQT
- ZYXI Strong Buy
- Analyst Count
- MQT 0
- ZYXI 2
- Target Price
- MQT N/A
- ZYXI $14.00
- AVG Volume (30 Days)
- MQT 52.5K
- ZYXI 113.1K
- Earning Date
- MQT 01-01-0001
- ZYXI 10-24-2024
- Dividend Yield
- MQT 4.60%
- ZYXI N/A
- EPS Growth
- MQT N/A
- ZYXI N/A
- EPS
- MQT N/A
- ZYXI 0.15
- Revenue
- MQT N/A
- ZYXI $193,665,000.00
- Revenue This Year
- MQT N/A
- ZYXI $10.70
- Revenue Next Year
- MQT N/A
- ZYXI $19.78
- P/E Ratio
- MQT N/A
- ZYXI $54.84
- Revenue Growth
- MQT N/A
- ZYXI 4.21
- 52 Week Low
- MQT $8.59
- ZYXI $7.15
- 52 Week High
- MQT $10.67
- ZYXI $13.77
- Technical
- Relative Strength Index (RSI)
- MQT 40.07
- ZYXI 47.10
- Support Level
- MQT $10.36
- ZYXI $7.70
- Resistance Level
- MQT $10.62
- ZYXI $9.33
- Average True Range (ATR)
- MQT 0.09
- ZYXI 0.41
- MACD
- MQT -0.00
- ZYXI -0.11
- Stochastic Oscillator
- MQT 14.29
- ZYXI 25.15
About MQT Blackrock MuniYield Quality Fund II Inc.
BLACKROCK MUNIYIELD QUALITY FUND II, INC. is a closed-end fund. Its objective is to provide shareholders with as high a level of current income exempt from federal income taxes as is consistent with its investment policies and prudent investment management. It invests in various sectors such as Transportation, Utilities, Health, County/City/Special District/School District, Education, and Housing.
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.